ARDX Ardelyx, Inc.
$3.58▼ -1.11%
Healthcare
Other
After hours
$3.59▲ +0.28%
Sep 11, 7:30 PM ET
Volume 5.69M
Avg Volume (10D) 4.01M
Key Metrics & Fundamentals
Market Cap
$924.31M
P/E Ratio
–
Div Yield
–%
52W Range
3.56 - 8.40
% vs 50 MA
-20.30%
% vs 200 MA
-38.45%
RSI-14
27.2
MACD Histogram
+0.0300
Beta (1Y vs SPY)
0.81
Free Cash Flow
-$6.41M
Gross Rev
$120.88M
Gross Profit
$115.12M
EBITDA
-$9.78M
COGS
$5.76M
Operating Exp
$127.54M
Operating Income
-$12.43M
EBIT
-$12.43M
Pretax Income
-$16.61M
Net Income
-$16.72M
EPS (Diluted)
-0.07
Price & Volume History
Loading chart…
Recent News
Hyperphosphatemia Market Insight, Epidemiology, and Market Forecast to 2036 Now Available — See Which Novel Mechanism Could Unseat Sevelamer as Phosphate Binders Face a Pill-Burden Reckoning
GlobeNewswire · Sep 8, 2026 2:45 PM
Ardelyx to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 1, 2026 11:30 AM
Ardelyx (ARDX) Cuts Guidance On Payer Hurdles As Fair Value Debate Heats Up
Simply Wall St. · Aug 22, 2026 6:08 PM
Valeris Welcomes Patient Services Veteran Lauren Cole to Lead Commercial Strategy
PR Newswire · Aug 18, 2026 12:00 PM
Ardelyx (ARDX) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 14, 2026 12:44 AM
Ardelyx (ARDX) Is Down 19.7% After Raising IBSRELA Revenue Guidance And Narrowing Losses
Simply Wall St. · Aug 11, 2026 12:19 AM
Ardelyx (ARDX) Posts Record Revenue, Is The Stock Still 70% Undervalued?
Simply Wall St. · Aug 7, 2026 3:13 PM
Wedbush Adjusts Price Target on Ardelyx to $9 From $19, Maintains Outperform Rating
MT Newswires · Aug 7, 2026 1:49 PM
New Strong Sell Stocks for August 7th
Zacks · Aug 7, 2026 8:34 AM
Ardelyx Inc (ARDX) (Q2 2026) Earnings Call Highlights: Record Revenue of $118M Driven by Strong ...
GuruFocus.com · Aug 7, 2026 5:10 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See ARDX's money flow as a full page
Social Sentiment
No Reddit posts found for ARDX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.